HIV & AIDS

Developing effective vaccines against SARS-CoV-2 and HIV

Researchers led by Raghavan Varadarajan, professor at the Molecular Biophysics Unit, Indian Institute of Science (IISc), are working toward developing effective vaccine strategies against two viruses: SARS-CoV-2 and HIV.

Diseases, Conditions, Syndromes

Pfizer reports encouraging, very early vaccine test results

The first of four experimental COVID-19 vaccines being tested by Pfizer and its German partner BioNTech showed encouraging results in very early testing of 45 people, the companies said Wednesday.

HIV & AIDS

Four decades on, where's the HIV vaccine?

In the four decades since the first cases of what would come to be known as AIDS were documented, scientists have made huge strides in HIV treatment, transforming what was once a death sentence to a manageable condition.

HIV & AIDS

HVTN 505 vaccine induced antibodies nonspecific for HIV

A study by researchers at the National Institute of Allergy and Infectious Diseases and Duke University helps explain why the candidate vaccine used in the HVTN 505 clinical trial was not protective against HIV infection ...

page 6 from 40